Brinker Capital Investments’s Integra LifeSciences IART Stock Holding History

Brinker Capital Investments’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Buy	67,077 +4,937	+8%	+$69K	0.01%	1055
2026 Q1	$585K	Buy	62,140 +4,100	+7%	+$45K	0.01%	1383
2025 Q4	$721K	Buy	58,040 +15,725	+37%	+$209K	0.01%	1418
2025 Q3	$606K	Buy	42,315 +445	+1%	+$6.1K	﹤0.01%	1465
2025 Q2	$514K	Buy	41,870 +9,856	+31%	+$143K	﹤0.01%	1495
2025 Q1	$704K	Sell	32,014 -95	-0.3%	-$2.23K	0.01%	1245
2024 Q4	$728K	Buy	+32,109	New	+$701K	0.01%	1205

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Brinker Capital Investments's IART Position: Q2 2026 in Review

Brinker Capital Investments increased its Integra LifeSciences (IART) stake by 7.9% in Q2 2026, buying an estimated $69K and bringing the position to 67,077 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #1055.

Brinker Capital Investments first reported a position in IART in Q4 2024 and has held it in 7 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Brinker Capital Investments held 67,077 shares of Integra LifeSciences worth $1.2M as of Q2 2026.
Brinker Capital Investments bought 4,937 Integra LifeSciences shares in Q2 2026, an estimated $69K.
Integra LifeSciences made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1055 holding.
Brinker Capital Investments first reported a position in Integra LifeSciences in Q4 2024 and has held it in 7 quarters since.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.